Fundz

Repare Therapeutics Receives $1.5 Million (¥200 Million) Payment From Ono Pharmaceuticals

RECENTLY ACQUIREDJan 19, 2023

Amount Raised

$1.5 Million

Round Type

Seed

BiotechnologyHealth CareTherapeutics

Investors

Repare

Description

Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a leading clinical-stage precision oncology company, today announced that the Company has received an approximately $1.5 million (¥200 million) research service payment from Ono Pharmaceutical Co., Ltd. (“Ono”). The payment reflects achievement of a specified research trigger, under the companies’ 2019 Strategic Partnership Agreement (“Ono Agreement”)

Quick answer

Repare Therapeutics raised $1.5 Million in a Seed round, dated January 19, 2023. Investors: Repare.

How much did Repare Therapeutics raise?
Repare Therapeutics raised $1.5 Million in a Seed round on January 19, 2023.
Who invested in Repare Therapeutics?
Repare is named as investors in this round.
What does Repare Therapeutics do?
Repare Therapeutics is a clinical-stage precision oncology company enabled by its proprietary synthetic lethality approach to the discovery and development of novel therapeutics.
Where is Repare Therapeutics based and how big is it?
Fundz records about 67 employees.
Who are the decision-makers at Repare Therapeutics?
Fundz holds 1 contact at Repare Therapeutics. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Therapeutics and Biotechnology around the same time

Companies in the same sectors as Repare Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • GenoME Diagnostics raised $1.8M (Seed) on March 3, 2023.
  • Chroma Medicine raised $135M (Series B) on March 1, 2023.
  • Wilson Wolf Manufacturing raised an undisclosed amount on March 1, 2023.
  • Aprea Therapeutics raised an undisclosed amount (Funding Round) on February 28, 2023.
  • Tessera Defense & Homeland Security Inc. raised $1.5M (Seed) on February 27, 2023.
  • Transcend Therapeutics raised an undisclosed amount (Series A) on February 23, 2023.

Who to call at Repare Therapeutics, and when

A new round usually means Repare Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Repare Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Repare Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Repare Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Repare Therapeutics

About

Repare Therapeutics is a clinical-stage precision oncology company enabled by its proprietary synthetic lethality approach to the discovery and development of novel therapeutics. Repare Therapeutics has developed highly targeted cancer therapies focused on genomic instability, including DNA damage repair. The Company’s clinical-stage pipeline includes RP-3467, a Phase 1 Polθ ATPase inhibitor; and RP-1664, a Phase 1 PLK4 inhibitor.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Repare Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Repare Therapeutics's next move

See what Strategic adds

Repare Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.